Semler Scientific, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Eric Semler, a director of Semler Scientific, Inc., reported the disposal of common stock and stock options following the company's merger with Strive, Inc. effective January 16, 2026.
Douglas Murphy-Chutorian, CEO of Semler Scientific, reported the disposal of common stock and conversion of stock options following the company's merger with Strive, Inc.
Director Daniel S. Messina's Semler Scientific shares and options were converted into Strive Class A common stock and options following the merger effective January 16, 2026.
Semler Scientific director Natalie Brunell's stock options were converted into Strive Class A common stock options following the merger effective January 16, 2026.
Semler Scientific Director William H. Chang reported the disposition of common stock and stock options following the company's merger with Strive, Inc., effective January 16, 2026.
Semler Scientific files an SEC Form 425 detailing a social media post regarding its proposed acquisition by Strive, Inc., and outlining associated risks and where to find further information.
Semler Scientific's Director of Bitcoin Strategy made social media posts regarding the proposed acquisition by Strive, Inc., prompting an SEC filing.
Strive's Chief Risk Officer discusses the company's Bitcoin treasury strategy, the Semler Scientific merger, and the future of digital credit in a rapidly evolving market.
Strive, Inc. issues a cautionary statement regarding its proposed business combination with Semler Scientific, Inc., highlighting risks and forward-looking statements.
Semler Scientific's Director of Bitcoin Strategy, Joe Burnett, posted on X.com regarding the proposed acquisition of Semler Scientific by Strive, Inc., prompting an SEC filing.
Semler Scientific's proposed acquisition by Strive, Inc. moves forward with SEC filings and shareholder solicitation, as a director comments on social media.
Semler Scientific's Director of Bitcoin Strategy posted on X.com about the proposed acquisition by Strive, Inc.
Semler Scientific Director William H. Chang was granted 4,000 stock options with an exercise price of $17.78, exercisable immediately.
Semler Scientific, Inc. Director Natalie Brunell was granted 4,000 stock options exercisable at $17.78 per share.
Semler Scientific Director Eric Semler acquired 4,000 stock options exercisable at $17.78 per share, effective January 2, 2026.
Semler Scientific's CEO, Douglas Murphy-Chutorian, was granted 15,000 stock options exercisable at $17.78 per share.
Semler Scientific director Daniel S. Messina was granted 4,000 stock options with an exercise price of $17.78, effective January 2, 2026.
Semler Scientific's Director of Bitcoin Strategy communicated updates on the proposed acquisition by Strive, Inc., highlighting ongoing regulatory processes.
Strive, Inc. reposts communication regarding its proposed business combination with Semler Scientific, Inc., highlighting forward-looking statements and associated risks.
Strive, Inc. board member James Lavish reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.
Semler Scientific's Director of Bitcoin Strategy shared posts on X.com regarding the proposed acquisition by Strive, Inc., prompting SEC filings for stockholder approval.
Strive, Inc. and Semler Scientific, Inc. communicated details regarding their proposed business combination, including cautionary statements on forward-looking information.
Strive Inc. and Semler Scientific Inc. issued a cautionary statement regarding their proposed business combination, highlighting various risks and uncertainties.
Strive's Chief Risk Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, including cautionary forward-looking statements.
Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.
Strive, Inc. and Semler Scientific, Inc. have issued a communication regarding their proposed business combination, highlighting potential benefits and significant risks.
Strive's Chief Risk Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, highlighting forward-looking statements and associated risks.
Semler Scientific is soliciting stockholder votes for a special meeting on January 13, 2026, to approve its proposed acquisition by Strive, Inc.
Strive, Inc. reposted a communication regarding its proposed business combination with Semler Scientific, Inc., highlighting forward-looking statements and associated risks.
Strive Inc. filed a Form 425 regarding its proposed business combination with Semler Scientific, emphasizing risks and forward-looking statements.